ALOPECIA
A PHASE, II, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY OF THE SAFETY AND PRELIMINARY EFFICACY OF MTS-O1, FOR THE PREVENTION OF ALOPECIA INDUCED BY WHOLE BRAIN RADIOTHERAPY
Eligibility Criteria
At least 18 years of age
Proven metastatic cancer to the brain
No metastases to the scalp or scalp wound(s)
Treatment SystemThe UA Department of Radiation Oncology is one of the few hospitals in the Southwest to offer the TomoTherapy HiArt® treatment system, a safer way to deliver radiation treatment to cancer patients. More >>
New CT Simulator TechnologyOur new simulator CT provides state of the art imaging for precise treatment planning. More>>
